Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Orally active GH secretagogues with a short duration of action

Sep. 13, 1996

New treatment for diabetic keratopathy

Sep. 13, 1996

Achiral inhibitors of carnitine palmitoyltransferase I

Sep. 13, 1996

Chugai's metabolic drug R&D pipeline

Sep. 13, 1996

Rapamycin in anemia

Sep. 13, 1996

Warner-Lambert profiles ACAT inhibitors with hypocholesterolemic and antiatherosclerotic activity

Sep. 13, 1996

Vitamin D3 derivatives for osteoporosis

Sep. 13, 1996

New estrogen agonists and antagonists

Sep. 13, 1996

Novel treatment for bone loss

Sep. 13, 1996

Meiji Seika discloses natural progesterone antagonists

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...